PURPOSE: We investigated pre- to post-diagnosis weight change and functional limitations in a cohort of breast cancer survivors. METHODS: A cohort of 1,841 early-stage breast cancer survivors provided information on pre- and post-diagnosis weight and physical function on average 2 years post-diagnosis. The mean number of limitations for each BMI category and each weight change category were compared using the Wilcoxon test. Cross-sectional associations between weight change, from 1 year prior to diagnosis to 2 years post-diagnosis, and functional limitations were determined using logistic regression. RESULTS: Women with BMI ≥ 30 kg/m(2) had significantly higher physical limitations compared to women with BMI < 25 kg/m(2) (2.06 vs 0.96 for moderate/severe limitations, 3.92 vs 3.27 for mild limitations, 1.31 vs 0.47 for lower body limitations, and 0.76 vs 0.49 for all other limitations; P < 0.0001). Women who reported a large weight gain (≥10% of pre-diagnosis weight) were more likely to report any limitation (OR = 1.79; 95% confidence interval (CI) = 1.23-2.61), a moderate/severe limitation (OR = 2.30; 95% CI = 1.75-3.02), and a lower body limitation (OR = 2.05; 95% CI = 1.53-2.76) compared to women who maintained weight within 5% of pre-diagnosis weight. However, associations between weight loss and functional limitations depended on pre-diagnosis BMI and comorbidity status. Among women without comorbidity, large weight loss (≥10% of pre-diagnosis weight) in normal-weight women was associated with higher risk of functional limitations, whereas among overweight/obese women, large weight loss appeared to be associated with a lower risk of limitations. Among women with comorbidity, moderate weight loss in overweight/obese women was associated with a higher risk of a moderate/severe physical limitation. CONCLUSIONS: Large weight gain was associated with a higher risk of physical functional limitations, but associations between weight loss and functional limitations may depend on initial BMI and comorbidity status. IMPLICATIONS FOR CANCER SURVIVORS: In this study we found that both weight loss and weight gain among breast cancer survivors were associated with a higher risk of physical functional limitations. Weight maintenance, therefore, may be an important factor in preventing and/or reducing the risk of functional decline in breast cancer survivors.
PURPOSE: We investigated pre- to post-diagnosis weight change and functional limitations in a cohort of breast cancer survivors. METHODS: A cohort of 1,841 early-stage breast cancer survivors provided information on pre- and post-diagnosis weight and physical function on average 2 years post-diagnosis. The mean number of limitations for each BMI category and each weight change category were compared using the Wilcoxon test. Cross-sectional associations between weight change, from 1 year prior to diagnosis to 2 years post-diagnosis, and functional limitations were determined using logistic regression. RESULTS:Women with BMI ≥ 30 kg/m(2) had significantly higher physical limitations compared to women with BMI < 25 kg/m(2) (2.06 vs 0.96 for moderate/severe limitations, 3.92 vs 3.27 for mild limitations, 1.31 vs 0.47 for lower body limitations, and 0.76 vs 0.49 for all other limitations; P < 0.0001). Women who reported a large weight gain (≥10% of pre-diagnosis weight) were more likely to report any limitation (OR = 1.79; 95% confidence interval (CI) = 1.23-2.61), a moderate/severe limitation (OR = 2.30; 95% CI = 1.75-3.02), and a lower body limitation (OR = 2.05; 95% CI = 1.53-2.76) compared to women who maintained weight within 5% of pre-diagnosis weight. However, associations between weight loss and functional limitations depended on pre-diagnosis BMI and comorbidity status. Among women without comorbidity, large weight loss (≥10% of pre-diagnosis weight) in normal-weight women was associated with higher risk of functional limitations, whereas among overweight/obesewomen, large weight loss appeared to be associated with a lower risk of limitations. Among women with comorbidity, moderate weight loss in overweight/obesewomen was associated with a higher risk of a moderate/severe physical limitation. CONCLUSIONS: Large weight gain was associated with a higher risk of physical functional limitations, but associations between weight loss and functional limitations may depend on initial BMI and comorbidity status. IMPLICATIONS FOR CANCER SURVIVORS: In this study we found that both weight loss and weight gain among breast cancer survivors were associated with a higher risk of physical functional limitations. Weight maintenance, therefore, may be an important factor in preventing and/or reducing the risk of functional decline in breast cancer survivors.
Authors: T W Weaver; L H Kushi; P G McGovern; J D Potter; S S Rich; R A King; J Whitbeck; J Greenstein; T A Sellers Journal: Int J Obes Relat Metab Disord Date: 1996-07
Authors: Soham Al Snih; Mukaila A Raji; Kyriakos S Markides; Kenneth J Ottenbacher; James S Goodwin Journal: J Am Geriatr Soc Date: 2005-10 Impact factor: 5.562
Authors: Anne B Newman; Jung Sun Lee; Marjolein Visser; Bret H Goodpaster; Stephen B Kritchevsky; Frances A Tylavsky; Michael Nevitt; Tamara B Harris Journal: Am J Clin Nutr Date: 2005-10 Impact factor: 7.045
Authors: Bette Caan; Barbara Sternfeld; Erica Gunderson; Ashley Coates; Charles Quesenberry; Martha L Slattery Journal: Cancer Causes Control Date: 2005-06 Impact factor: 2.506
Authors: W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey Journal: Am J Med Date: 1980-10 Impact factor: 4.965
Authors: Makenzie L Hawkins; Saundra S Buys; Lisa H Gren; Sara E Simonsen; Anne C Kirchhoff; Mia Hashibe Journal: J Cancer Surviv Date: 2016-11-11 Impact factor: 4.442
Authors: Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Don Dizon; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; Muhammad Raza; M Alma Rodriguez; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2014-10 Impact factor: 11.908
Authors: Lorraine T Dean; Angela DeMichele; Mously LeBlanc; Alisa Stephens-Shields; Susan Q Li; Chris Colameco; Morgan Coursey; Jun J Mao Journal: Breast Cancer Res Treat Date: 2015-09-29 Impact factor: 4.872
Authors: Kristine M Erlandson; Xiuhong Li; Alison G Abraham; Joseph B Margolick; Jordan E Lake; Frank J Palella; Susan L Koletar; Todd T Brown Journal: AIDS Date: 2016-01-28 Impact factor: 4.177
Authors: Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh Journal: PeerJ Date: 2015-11-10 Impact factor: 2.984